Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm) (NEWWAVE)
Varicose Veins
About this trial
This is an interventional treatment trial for Varicose Veins focused on measuring Endovenous laser ablation (EVLA)
Eligibility Criteria
Inclusion Criteria: Primary insufficiency of the great saphenous vein (GSV) and/or small saphenous vein (SSV) Patient candidate for endothermic treatment of the lower limbs CEAP: C2 - C6 Patient with a target vein diameter (GSV and/or SSV) >= 3 mm throughout the target vein segment Patient affiliated or beneficiary of a social security scheme Patient having signed the informed consent Exclusion Criteria: Patient with a current serious pathology and/or a life expectancy of less than 5 years Patient who has had a deep or superficial vein thrombosis in the previous 6 months Obliterating arteriopathy of the lower limb concerned, with an IPS < 0.8 or > 1.3 Patient with post-thrombotic obstructive syndrome at the popliteal and/or femoral and/or iliac stage on the ipsilateral lower limb Patient with primary or post-thrombotic axial deep venous reflux on the ipsilateral lower limb Suspicion of non-post-thrombotic iliac compression on echo-doppler Contraindication to the planned treatment technique Patient whose geographical distance is not compatible with the follow-up of the study Pregnant or breastfeeding women Patient linguistically or psychologically unable to understand the information given, to give informed consent or to answer the study questionnaires. Protected patients: Adults under guardianship, or other legal protection; Hospitalized without consent.
Sites / Locations
- Clinique PasteurRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
1940 nm
1470 nm
Endovenous laser at 1940 nm
Endovenous laser at 1470 nm